X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES STERLING BIOTECH SUVEN LIFESCIENCES/
STERLING BIOTECH
 
P/E (TTM) x 20.6 -0.4 - View Chart
P/BV x 3.9 0.0 27,212.6% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUVEN LIFESCIENCES   STERLING BIOTECH
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-18
STERLING BIOTECH
Dec-13
SUVEN LIFESCIENCES/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs25111 2,388.6%   
Low Rs1553 4,558.8%   
Sales per share (Unadj.) Rs49.126.8 183.3%  
Earnings per share (Unadj.) Rs9.7-15.0 -65.0%  
Cash flow per share (Unadj.) Rs11.4-5.5 -208.5%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs60.354.9 109.9%  
Shares outstanding (eoy) m127.28267.87 47.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.10.3 1,593.1%   
Avg P/E ratio x20.9-0.5 -4,493.5%  
P/CF ratio (eoy) x17.8-1.3 -1,400.0%  
Price / Book Value ratio x3.40.1 2,657.4%  
Dividend payout %15.40-   
Avg Mkt Cap Rs m25,8251,862 1,387.2%   
No. of employees `0001.11.4 79.2%   
Total wages/salary Rs m613547 112.1%   
Avg. sales/employee Rs Th5,832.65,303.3 110.0%   
Avg. wages/employee Rs Th571.5403.8 141.5%   
Avg. net profit/employee Rs Th1,153.8-2,959.0 -39.0%   
INCOME DATA
Net Sales Rs m6,2537,181 87.1%  
Other income Rs m23343 546.2%   
Total revenues Rs m6,4857,223 89.8%   
Gross profit Rs m1,982947 209.3%  
Depreciation Rs m2132,543 8.4%   
Interest Rs m464,377 1.1%   
Profit before tax Rs m1,955-5,931 -33.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718-1,924 -37.3%   
Profit after tax Rs m1,237-4,007 -30.9%  
Gross profit margin %31.713.2 240.4%  
Effective tax rate %36.732.4 113.2%   
Net profit margin %19.8-55.8 -35.5%  
BALANCE SHEET DATA
Current assets Rs m5,62214,335 39.2%   
Current liabilities Rs m1,16849,809 2.3%   
Net working cap to sales %71.2-494.0 -14.4%  
Current ratio x4.80.3 1,673.1%  
Inventory Days Days81403 20.2%  
Debtors Days Days36171 21.1%  
Net fixed assets Rs m3,32555,432 6.0%   
Share capital Rs m127268 47.5%   
"Free" reserves Rs m7,54713,935 54.2%   
Net worth Rs m7,67414,701 52.2%   
Long term debt Rs m149,478 0.1%   
Total assets Rs m9,13573,988 12.3%  
Interest coverage x43.2-0.4 -12,177.9%   
Debt to equity ratio x00.6 0.3%  
Sales to assets ratio x0.70.1 705.2%   
Return on assets %14.00.5 2,804.2%  
Return on equity %16.1-27.3 -59.1%  
Return on capital %26.0-6.4 -405.1%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m5,0661,860 272.4%   
Fx outflow Rs m2,00125 8,040.2%   
Net fx Rs m3,0651,835 167.0%   
CASH FLOW
From Operations Rs m6991,719 40.7%  
From Investments Rs m-6-3,148 0.2%  
From Financial Activity Rs m-5771,426 -40.5%  
Net Cashflow Rs m116-3 -3,420.6%  

Share Holding

Indian Promoters % 63.4 33.9 187.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 16.9 -  
Free float % 36.5 39.3 92.9%  
Shareholders   37,287 21,482 173.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   ALEMBIC LTD  SHASUN PHARMA  SANOFI INDIA  FDC LTD.  SUN PHARMA  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views on News

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Mar 22, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - GLENMARK PHARMA COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS